Nanomaterials for drug delivery, what’s next – Editorial
Saved in:
| Published in | Next materials Vol. 6; p. 100341 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
Elsevier Ltd
01.01.2025
Elsevier |
| Online Access | Get full text |
Cover
Loading…
| ArticleNumber | 100341 |
|---|---|
| Author | Yu, Chengzhong Theivendran, Shevanuja |
| Author_xml | – sequence: 1 givenname: Shevanuja orcidid: 0000-0003-3359-0249 surname: Theivendran fullname: Theivendran, Shevanuja email: s.theivendran@uq.edu.au – sequence: 2 givenname: Chengzhong surname: Yu fullname: Yu, Chengzhong |
| BookMark | eNp9kEFOwzAQRS1UJErpDVjkAKTYjuPEEkJCVYFKFWy6txx7XBy1MXJCaXe9Ayuu15OQEIRYsZrRaP6bP_8cDSpfAUKXBE8IJvy6nFS7jWpgQjFl7QgnjJygIRVMxDml-eBPf4bGdV1ijKkQhDMyRDdPqvKdPDi1riPrQ2TC2yoysHZbCPur6P1FNcfDZx1VsGui4-EjmhnX-G7_Ap3aVgXjnzpCy_vZcvoYL54f5tO7RaypyJqYFoKnOtMpVWmGeQE2U0JQZkWegQHOrU4sTQwWIskAsElJ65gzURCuiElGaN5jjVelfA1uo8JeeuXk98CHlVShcXoNMjGEYeCaElUwECTXVrVnbIJ5xjNTtCzWs3TwdR3A_vIIll2espR9nrLLU_Z5trLbXgbtm1sHQdbaQaXBuAC6aY24_wFfluSCzQ |
| Cites_doi | 10.1073/pnas.2121098119 10.1016/j.addr.2012.09.037 10.3389/fmolb.2021.804396 10.1039/D2NA00439A 10.1038/s41467-022-35637-z 10.1007/s13346-021-00954-1 10.3389/fimmu.2021.681062 10.3389/fbioe.2020.00922 10.1021/acsnano.8b02037 10.1186/s12951-018-0392-8 10.1038/s41573-020-0090-8 10.3892/br.2021.1418 |
| ContentType | Journal Article |
| Copyright | 2024 The Authors |
| Copyright_xml | – notice: 2024 The Authors |
| DBID | 6I. AAFTH AAYXX CITATION DOA |
| DOI | 10.1016/j.nxmate.2024.100341 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 2949-8228 |
| ExternalDocumentID | oai_doaj_org_article_3d140e6c21ab4e918cfaf98f306767db 10_1016_j_nxmate_2024_100341 S2949822824002387 |
| GroupedDBID | 0R~ 6I. AAFTH AAXUO AAYWO ADVLN AFJKZ AITUG ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP EBS FDB GROUPED_DOAJ M41 M~E ROL AALRI AAYXX ACVFH ADCNI AEUPX AFPUW AIGII AKBMS AKYEP CITATION |
| ID | FETCH-LOGICAL-c297t-2b965c7c52a5706bef7a9924f987ede66fc3f23d09937ee0d51294649b16a1d3 |
| IEDL.DBID | DOA |
| ISSN | 2949-8228 |
| IngestDate | Wed Aug 27 01:26:09 EDT 2025 Sun Jul 06 05:07:15 EDT 2025 Sat May 24 17:05:27 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| License | This is an open access article under the CC BY license. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c297t-2b965c7c52a5706bef7a9924f987ede66fc3f23d09937ee0d51294649b16a1d3 |
| ORCID | 0000-0003-3359-0249 |
| OpenAccessLink | https://doaj.org/article/3d140e6c21ab4e918cfaf98f306767db |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_3d140e6c21ab4e918cfaf98f306767db crossref_primary_10_1016_j_nxmate_2024_100341 elsevier_sciencedirect_doi_10_1016_j_nxmate_2024_100341 |
| PublicationCentury | 2000 |
| PublicationDate | January 2025 2025-01-00 2025-01-01 |
| PublicationDateYYYYMMDD | 2025-01-01 |
| PublicationDate_xml | – month: 01 year: 2025 text: January 2025 |
| PublicationDecade | 2020 |
| PublicationTitle | Next materials |
| PublicationYear | 2025 |
| Publisher | Elsevier Ltd Elsevier |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
| References | Allen, Cullis (bib3) 2013 Wang, Fang, Liu, Lyu, Ma, Fu (bib16) 2024 Mitchell, Billingsley, Haley, Wechsler, Peppas, Langer (bib5) 2021 Huang, Kłodzińska, Wan, Nielsen (bib7) 2021 Yan, Fan, Ji, Zhang, Dong, Zhu (bib15) 2024 Rambaran, Schirhagl (bib1) 2022 Hu, Fang, Ge, Li (bib6) 2022 Sim, Wong (bib2) 2021 Lyons, Plantz, Hsu, Hsu, Minardi (bib10) 2020 Han, Gong, Xue, Billingsley, El-Mayta, Shepherd, Alameh, Weissman, Mitchell (bib14) 2023 Wang, Li, Zhao, Dou, An, Tao, Xu, Jia, Lu, Zhang, Hu (bib13) 2018 Singh, Chakraborty, Wong, Hefner, Stuart, Qadir, Mukhopadhyay, Bachmaier, Shin, Rehman, Malik (bib9) 2022 Patra, Das, Fraceto, Campos, Rodriguez-Torres, Acosta-Torres, Diaz-Torres, Grillo, Swamy, Sharma, Habtemariam, Shin (bib4) 2018 Laroui, Sitaraman, Merlin (bib12) 2012; Vol. 509 Gu, Zhang, Wu, Zhuge (bib8) 2022 Horwitz, Bickerton, La Cava (bib11) 2021 Hu (10.1016/j.nxmate.2024.100341_bib6) 2022; 3 Wang (10.1016/j.nxmate.2024.100341_bib13) 2018; 12 Huang (10.1016/j.nxmate.2024.100341_bib7) 2021; 11 Wang (10.1016/j.nxmate.2024.100341_bib16) 2024; 2 Han (10.1016/j.nxmate.2024.100341_bib14) 2023; 14 Allen (10.1016/j.nxmate.2024.100341_bib3) 2013; 65 Laroui (10.1016/j.nxmate.2024.100341_bib12) 2012; Vol. 509 Yan (10.1016/j.nxmate.2024.100341_bib15) 2024; 2 Sim (10.1016/j.nxmate.2024.100341_bib2) 2021; 14 Patra (10.1016/j.nxmate.2024.100341_bib4) 2018; 16 Rambaran (10.1016/j.nxmate.2024.100341_bib1) 2022; 4 Singh (10.1016/j.nxmate.2024.100341_bib9) 2022; 119 Mitchell (10.1016/j.nxmate.2024.100341_bib5) 2021; 20 Gu (10.1016/j.nxmate.2024.100341_bib8) 2022; 8 Horwitz (10.1016/j.nxmate.2024.100341_bib11) 2021; 12 Lyons (10.1016/j.nxmate.2024.100341_bib10) 2020; 8 |
| References_xml | – start-page: 101 year: 2021 end-page: 124 ident: bib5 article-title: Engineering precision nanoparticles for drug delivery publication-title: Nat. Rev. Drug Discov. – year: 2021 ident: bib11 article-title: Strategies to use nanoparticles to generate CD4 and CD8 regulatory T cells for the treatment of SLE and other autoimmune diseases publication-title: Front. Immunol. – year: 2022 ident: bib9 article-title: Nanoparticle targeting of de novo profibrotic macrophages mitigates lung fibrosis publication-title: Proc. Natl. Acad. Sci. – start-page: 8943 year: 2018 end-page: 8960 ident: bib13 article-title: Targeted therapy of atherosclerosis by a broad-spectrum reactive oxygen species scavenging nanoparticle with intrinsic anti-inflammatory activity publication-title: ACS Nano – start-page: 1634 year: 2021 end-page: 1654 ident: bib7 article-title: Nanoparticle-mediated pulmonary drug delivery: state of the art towards efficient treatment of recalcitrant respiratory tract bacterial infections publication-title: Drug Deliv. Transl. Res. – volume: Vol. 509 start-page: 101 year: 2012 end-page: 125 ident: bib12 article-title: Chapter six - Gastrointestinal Delivery of Anti-inflammatory Nanoparticles publication-title: Methods in Enzymology – year: 2022 ident: bib6 article-title: Nanotechnology for cardiovascular diseases publication-title: Innovation – year: 2024 ident: bib16 article-title: Spike nanoparticles: from design to biomedical applications publication-title: Materials – start-page: 42 year: 2021 ident: bib2 article-title: Nanotechnology and its use in imaging and drug delivery (Review) publication-title: Biomed. Rep. – year: 2022 ident: bib8 article-title: Nanotechnology in drug delivery for liver fibrosis publication-title: Front. Mol. Biosci. – year: 2024 ident: bib15 article-title: Photodynamic therapy strategy based on nanoscale metal-organic frameworks publication-title: Materials – start-page: 36 year: 2013 end-page: 48 ident: bib3 article-title: Liposomal drug delivery systems: From concept to clinical applications publication-title: Adv. Drug Deliv. Rev. – year: 2020 ident: bib10 article-title: Nanostructured biomaterials for bone regeneration publication-title: Front. Bioeng. Biotechnol. – start-page: 3664 year: 2022 end-page: 3675 ident: bib1 article-title: Nanotechnology from lab to industry – a look at current trends publication-title: Nanoscale Adv. – start-page: 71 year: 2018 ident: bib4 article-title: Nano based drug delivery systems: recent developments and future prospects publication-title: J. Nanobiotechnology – start-page: 75 year: 2023 ident: bib14 article-title: Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis publication-title: Nat. Commun. – volume: 119 issue: 15 year: 2022 ident: 10.1016/j.nxmate.2024.100341_bib9 article-title: Nanoparticle targeting of de novo profibrotic macrophages mitigates lung fibrosis publication-title: Proc. Natl. Acad. Sci. doi: 10.1073/pnas.2121098119 – volume: 65 start-page: 36 issue: 1 year: 2013 ident: 10.1016/j.nxmate.2024.100341_bib3 article-title: Liposomal drug delivery systems: From concept to clinical applications publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2012.09.037 – volume: 8 year: 2022 ident: 10.1016/j.nxmate.2024.100341_bib8 article-title: Nanotechnology in drug delivery for liver fibrosis publication-title: Front. Mol. Biosci. doi: 10.3389/fmolb.2021.804396 – volume: 4 start-page: 3664 issue: 18 year: 2022 ident: 10.1016/j.nxmate.2024.100341_bib1 article-title: Nanotechnology from lab to industry – a look at current trends publication-title: Nanoscale Adv. doi: 10.1039/D2NA00439A – volume: 2 year: 2024 ident: 10.1016/j.nxmate.2024.100341_bib16 article-title: Spike nanoparticles: from design to biomedical applications publication-title: Materials – volume: 14 start-page: 75 issue: 1 year: 2023 ident: 10.1016/j.nxmate.2024.100341_bib14 article-title: Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis publication-title: Nat. Commun. doi: 10.1038/s41467-022-35637-z – volume: 11 start-page: 1634 issue: 4 year: 2021 ident: 10.1016/j.nxmate.2024.100341_bib7 article-title: Nanoparticle-mediated pulmonary drug delivery: state of the art towards efficient treatment of recalcitrant respiratory tract bacterial infections publication-title: Drug Deliv. Transl. Res. doi: 10.1007/s13346-021-00954-1 – volume: 12 year: 2021 ident: 10.1016/j.nxmate.2024.100341_bib11 article-title: Strategies to use nanoparticles to generate CD4 and CD8 regulatory T cells for the treatment of SLE and other autoimmune diseases publication-title: Front. Immunol. doi: 10.3389/fimmu.2021.681062 – volume: 3 issue: 2 year: 2022 ident: 10.1016/j.nxmate.2024.100341_bib6 article-title: Nanotechnology for cardiovascular diseases publication-title: Innovation – volume: 8 year: 2020 ident: 10.1016/j.nxmate.2024.100341_bib10 article-title: Nanostructured biomaterials for bone regeneration publication-title: Front. Bioeng. Biotechnol. doi: 10.3389/fbioe.2020.00922 – volume: 12 start-page: 8943 issue: 9 year: 2018 ident: 10.1016/j.nxmate.2024.100341_bib13 article-title: Targeted therapy of atherosclerosis by a broad-spectrum reactive oxygen species scavenging nanoparticle with intrinsic anti-inflammatory activity publication-title: ACS Nano doi: 10.1021/acsnano.8b02037 – volume: 16 start-page: 71 issue: 1 year: 2018 ident: 10.1016/j.nxmate.2024.100341_bib4 article-title: Nano based drug delivery systems: recent developments and future prospects publication-title: J. Nanobiotechnology doi: 10.1186/s12951-018-0392-8 – volume: 2 year: 2024 ident: 10.1016/j.nxmate.2024.100341_bib15 article-title: Photodynamic therapy strategy based on nanoscale metal-organic frameworks publication-title: Materials – volume: 20 start-page: 101 issue: 2 year: 2021 ident: 10.1016/j.nxmate.2024.100341_bib5 article-title: Engineering precision nanoparticles for drug delivery publication-title: Nat. Rev. Drug Discov. doi: 10.1038/s41573-020-0090-8 – volume: Vol. 509 start-page: 101 year: 2012 ident: 10.1016/j.nxmate.2024.100341_bib12 article-title: Chapter six - Gastrointestinal Delivery of Anti-inflammatory Nanoparticles – volume: 14 start-page: 42 issue: 5 year: 2021 ident: 10.1016/j.nxmate.2024.100341_bib2 article-title: Nanotechnology and its use in imaging and drug delivery (Review) publication-title: Biomed. Rep. doi: 10.3892/br.2021.1418 |
| SSID | ssj0002991641 |
| Score | 2.2787864 |
| SourceID | doaj crossref elsevier |
| SourceType | Open Website Index Database Publisher |
| StartPage | 100341 |
| Title | Nanomaterials for drug delivery, what’s next – Editorial |
| URI | https://dx.doi.org/10.1016/j.nxmate.2024.100341 https://doaj.org/article/3d140e6c21ab4e918cfaf98f306767db |
| Volume | 6 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV27TsMwFLVQJxYEAkR5yQMjEYnjRyyxAGpVIZWpSN0sP6GopKikAhbUf2Di9_ol2HmgsMDCkiGK7Phc555zo-t7ATjBWmpCZRzpRJsIu8x5P6h1xLkh1qXKoTQcTh7e0MEtvh6TcavVV8gJq8oDV8CdpcaHAJZqlEiFLU8y7aTjmQtSlzKjgvf1nNcKpoIPRkH24KQ5K1cmdOWvj7KsjIlwyA1IcfKDi8qS_S1KatFMfxNs1PoQXlTvtQXWbL4Nzr0PnIVhy90Cvc6EZr64g8ZOQ1rF2yl8uZfFavn5DHPvbOFq-QF7ZhLqf8jpDhj1e6OrQVS3PYg04qyIkOKUaKYJkoTFVFnHJPdhkl81s8ZS6nTqITRxkBbWxiZwNqaYq4TKxKS7oJPPcrsHICFaa8Wl1SzD0gPIDI4z_00TxTiVvAuiZv3iqSpuIZqsrwdR4SUCXqLCqwsuA0jfz4bS1OUNbzBRG0z8ZbAuYA3Eomb5ir39UJNfp9__j-kPwDoKLXzLvyiHoFPMF_bI64pCHZdbyF-H770vrSrPFw |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nanomaterials+for+drug+delivery%2C+what%E2%80%99s+next+%E2%80%93+Editorial&rft.jtitle=Next+materials&rft.au=Theivendran%2C+Shevanuja&rft.au=Yu%2C+Chengzhong&rft.date=2025-01-01&rft.pub=Elsevier+Ltd&rft.issn=2949-8228&rft.eissn=2949-8228&rft.volume=6&rft_id=info:doi/10.1016%2Fj.nxmate.2024.100341&rft.externalDocID=S2949822824002387 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2949-8228&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2949-8228&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2949-8228&client=summon |